Bangladesh vs Democratic Republic of Congo: The number of people with susceptibility test result for rifampicin

Bangladesh
82,924
in 2021
Democratic Republic of Congo
28,577
in 2021
Bangladesh rank
7th
Democratic Republic of Congo rank
10th

The number of people with susceptibility test result for rifampicin over time

  • Bangladesh
  • Democratic Republic of Congo
020.0k40.0k60.0k80.0k201720192021

How they compare

Bangladesh currently reports 82,924 against 28,577 in Democratic Republic of Congo, a difference of 54,347.

That makes Bangladesh's figure about 2.9 times Democratic Republic of Congo's.

Across all 5 years both countries report, Bangladesh has been ahead every year.

Bangladesh ranks 7th and Democratic Republic of Congo ranks 10th of 155 countries.

Bangladesh has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Bangladesh Democratic Republic of Congo Difference Ahead
2010s 39,340 4,788 34,552 Bangladesh
2020s 65,400 19,926 45,475 Bangladesh

Averages of every year both report within each decade.

Frequently asked questions

Which has higher the number of people with susceptibility test result for rifampicin, Bangladesh or Democratic Republic of Congo?
Bangladesh, at 82,924 against 28,577 in Democratic Republic of Congo as of 2021.
What is the difference in the number of people with susceptibility test result for rifampicin between Bangladesh and Democratic Republic of Congo?
54,347, with Bangladesh ahead.
How many years of comparable data are there for Bangladesh and Democratic Republic of Congo?
5 years are reported by both, from 2017 to 2021.
How do Bangladesh and Democratic Republic of Congo rank globally for the number of people with susceptibility test result for rifampicin?
Bangladesh ranks 7th and Democratic Republic of Congo ranks 10th of 155 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Bangladesh vs Democratic Republic of Congo: The number of people with susceptibility test result for rifampicin. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 18 September 2026, from https://health.statizoid.com/compare/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/bangladesh/congo-dem-rep/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/bangladesh/congo-dem-rep/">Bangladesh vs Democratic Republic of Congo: The number of people with susceptibility test result for rifampicin</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
157 places, 785 data points, 2017–2021
Last refreshed